159 related articles for article (PubMed ID: 10525849)
1. Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions.
Asano T
Crit Rev Neurosurg; 1999 Sep; 9(5):303-318. PubMed ID: 10525849
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Asano T; Matsui T
Cell Mol Neurobiol; 1999 Feb; 19(1):31-44. PubMed ID: 10079963
[TBL] [Abstract][Full Text] [Related]
3. Morphometric analysis of monkey cerebral arteries exposed in vivo to whole blood, oxyhemoglobin, methemoglobin, and bilirubin.
Macdonald RL; Weir BK; Grace MG; Martin TP; Doi M; Cook DA
Blood Vessels; 1991; 28(6):498-510. PubMed ID: 1782405
[TBL] [Abstract][Full Text] [Related]
4. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
Macdonald RL; Weir BK; Runzer TD; Grace MG; Poznansky MJ
Neurosurgery; 1992 Apr; 30(4):529-39. PubMed ID: 1584351
[TBL] [Abstract][Full Text] [Related]
5. Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity.
Ishiguro M; Morielli AD; Zvarova K; Tranmer BI; Penar PL; Wellman GC
Circ Res; 2006 Nov; 99(11):1252-60. PubMed ID: 17068294
[TBL] [Abstract][Full Text] [Related]
6. Functional changes in cultured strips of canine cerebral arteries after prolonged exposure to oxyhemoglobin.
Yoshimoto Y; Kim P; Sasaki T; Kirino T; Takakura K
J Neurosurg; 1995 Nov; 83(5):867-74. PubMed ID: 7472556
[TBL] [Abstract][Full Text] [Related]
7. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
Pluta RM
Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral vasospasm and lipoperoxide damage--morphological localization and measurement of lipoperoxide in prolonged cerebral vasospasm].
Tokoro K
No Shinkei Geka; 1984 Aug; 12(9):1049-58. PubMed ID: 6390241
[TBL] [Abstract][Full Text] [Related]
9. [Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Therapeutic value of treatment with calcium antagonists, hypervolemic hemodilution and induced arterial hypertension].
Hansen D; Hannemann L; Specht M; Schaffartzik W
Anaesthesist; 1995 Apr; 44(4):219-29. PubMed ID: 7785750
[TBL] [Abstract][Full Text] [Related]
10. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Findlay JM; Macdonald RL; Weir BK
Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm.
Wickman G; Lan C; Vollrath B
Circ Res; 2003 Apr; 92(7):809-16. PubMed ID: 12637369
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and pathophysiology of cerebral vasospasm following subarachnoid hemorrhage.
Pasqualin A
J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):15-21. PubMed ID: 9800597
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.
Afshar JK; Pluta RM; Boock RJ; Thompson BG; Oldfield EH
J Neurosurg; 1995 Jul; 83(1):118-22. PubMed ID: 7782826
[TBL] [Abstract][Full Text] [Related]
15. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C and cerebral vasospasm.
Laher I; Zhang JH
J Cereb Blood Flow Metab; 2001 Aug; 21(8):887-906. PubMed ID: 11487724
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats.
Satoh M; Parent AD; Zhang JH
Stroke; 2002 Mar; 33(3):775-81. PubMed ID: 11872903
[TBL] [Abstract][Full Text] [Related]
18. Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.
Macdonald RL; Weir BK; Young JD; Grace MG
J Neurosurg; 1992 Jan; 76(1):81-90. PubMed ID: 1727173
[TBL] [Abstract][Full Text] [Related]
19. A review of hemoglobin and the pathogenesis of cerebral vasospasm.
Macdonald RL; Weir BK
Stroke; 1991 Aug; 22(8):971-82. PubMed ID: 1866764
[TBL] [Abstract][Full Text] [Related]
20. Current perspective on the role of the thrombin receptor in cerebral vasospasm after subarachnoid hemorrhage.
Hirano K; Hirano M
J Pharmacol Sci; 2010; 114(2):127-33. PubMed ID: 20859063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
